News
A "sub-study" of a late-stage clinical trial found the drug, obicetrapib, significantly reduced levels of a certain type of ...
14h
Money Talks News on MSNCholesterol Fluctuations Linked to Alarming Dementia Risk, Study RevealsHigh cholesterol fluctuations have been linked to a higher risk of developing dementia, including Alzheimer's and vascular dementia. Maintaining stable cholesterol levels through a healthy diet, ...
NewAmsterdam Pharma’s push to show a cholesterol drug can prevent Alzheimer’s disease has passed another test. | NewAmsterdam ...
Shares of NewAmsterdam Pharma rose in premarket trading Monday after finding positive benefits for treating Alzheimer's Disease in its cholesterol drug study. Shares traded 9.2% higher ahead of the ...
Currently available PCSK9-targeting therapies are Amgen's Repatha (evolocumab) and Sanofi/Regeneron's Praluent (alirocumab), ...
Elderly persons who find it difficult to lift an object weighing 5 kilograms run the risk of developing a host of chronic ...
50m
Health on MSN6 Benefits of Beet Juice, Plus Nutrition and RisksBeet juice is rich in vitamins, minerals, and antioxidant compounds. It may help lower blood pressure and improve exercise ...
Explore the health benefits of turmeric and curcumin, what these ingredients do to the body, if they are the same, and how to ...
Analyst Says NewAmsterdam Stock Has Over 100% Upside, Citing 90% Success Probability For Obicetrapib
NewAmsterdam shared new Phase 3 data showing obicetrapib reduced LDL-C by 33% and impacted Alzheimer's biomarkers ahead of ...
NewAmsterdam Pharma Announces Positive Topline Alzheimer’s Disease Data from BROADWAY Clinical Trial
Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer’s disease biomarker in both ...
Content by Methodist Health System. June is Alzheimer’s and Brain Awareness Month, which means there’s no better time to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results